These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29333101)

  • 1. Variations in the
    Wang B; Hsu CJ; Chou CH; Lee HL; Chiang WL; Su CM; Tsai HC; Yang SF; Tang CH
    Int J Med Sci; 2018; 15(2):170-175. PubMed ID: 29333101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan.
    Chou CH; Chou YE; Chuang CY; Yang SF; Lin CW
    PLoS One; 2017; 12(2):e0171583. PubMed ID: 28152093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
    Wang B; Hsu CJ; Lee HL; Chou CH; Su CM; Yang SF; Tang CH
    Int J Med Sci; 2018; 15(6):653-658. PubMed ID: 29725257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Aurora Kinase A Polymorphism and Epithelial Growth Factor Receptor Mutations on the Clinicopathological Characteristics of Lung Adenocarcinoma.
    Yang PJ; Hsieh MJ; Lee CI; Yen CH; Wang HL; Chiang WL; Liu TC; Tsao TC; Lee CY; Yang SF
    Int J Environ Res Public Health; 2020 Oct; 17(19):. PubMed ID: 33050100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the AURKA and AURKC gene polymorphisms with an increased risk of gastric cancer.
    Mesic A; Rogar M; Hudler P; Juvan R; Komel R
    IUBMB Life; 2016 Aug; 68(8):634-44. PubMed ID: 27270838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of
    Huang CH; Chen CJ; Chen PN; Wang SS; Chou YE; Hung SC; Yang SF
    J Cancer; 2019; 10(6):1370-1374. PubMed ID: 31031846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Functional Genetic Variants of HOTAIR with Hepatocellular Carcinoma (HCC) Susceptibility in a Chinese Population.
    Li H; Tang XM; Liu Y; Li W; Chen Q; Pan Y
    Cell Physiol Biochem; 2017; 44(2):447-454. PubMed ID: 29141248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
    Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
    Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma.
    Wang B; Yeh CB; Lein MY; Su CM; Yang SF; Liu YF; Tang CH
    Int J Med Sci; 2016; 13(4):304-9. PubMed ID: 27076788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in AURKA and BRCA1 are associated with breast cancer susceptibility in a Chinese Han population.
    Ruan Y; Song AP; Wang H; Xie YT; Han JY; Sajdik C; Tian XX; Fang WG
    J Pathol; 2011 Dec; 225(4):535-43. PubMed ID: 21598251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Risk Associated with Genotype Polymorphisms of the Aurora Kinase a Gene (AURKA): a Case-Control Study in a High Altitude Ecuadorian Mestizo Population.
    López-Cortés A; Cabrera-Andrade A; Oña-Cisneros F; Echeverría C; Rosales F; Ortiz M; Tejera E; Paz-Y-Miño C
    Pathol Oncol Res; 2018 Jul; 24(3):457-465. PubMed ID: 28647900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development.
    Mesic A; Rogar M; Hudler P; Bilalovic N; Eminovic I; Komel R
    BMC Cancer; 2019 Sep; 19(1):919. PubMed ID: 31521144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic susceptibility of eight nonsynonymous polymorphisms in HLA-DRB1 gene to hepatocellular carcinoma in Han Chinese.
    Shi Y; Zhai W; Wang B; Zhao D; Jin H; Wang Y; Zhang J; An H; Fu Z; Zhao K; Lu C
    Oncotarget; 2016 Dec; 7(49):80935-80942. PubMed ID: 27821814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway.
    Wu M; Zhou Y; Fei C; Chen T; Yin X; Zhang L; Ren Z
    Int J Oncol; 2020 Sep; 57(3):845-857. PubMed ID: 32705157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
    Saad H; Zahran MA; Hendy O; Abdel-Samiee M; Bedair HM; Abdelsameea E
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3725-3734. PubMed ID: 33369474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma.
    Lu L; Han H; Tian Y; Li W; Zhang J; Feng M; Li Y
    Mol Carcinog; 2015 Nov; 54(11):1467-79. PubMed ID: 25284017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association analysis between the c.1804C>A genetic polymorphism of XRCC1 gene and risk of hepatocellular carcinoma in Chinese population.
    Liu Y; Zhang A; Liu Y; Dong J
    Med Oncol; 2014 Mar; 31(3):854. PubMed ID: 24526467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma.
    Chen C; Song G; Xiang J; Zhang H; Zhao S; Zhan Y
    Biochem Biophys Res Commun; 2017 Apr; 486(2):514-520. PubMed ID: 28322787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib.
    Necchi A; Pintarelli G; Raggi D; Giannatempo P; Colombo F
    Invest New Drugs; 2017 Aug; 35(4):524-528. PubMed ID: 28155045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin T9809C, an SNP located in 3'-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma.
    Hsieh YS; Tsai CM; Yeh CB; Yang SF; Hsieh YH; Weng CJ
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S625-33. PubMed ID: 22052111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.